Introduction
Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment, where a retinal "break" allows the ingress of fluid from the vitreous cavity to the subretinal space, resulting in retinal separation. It occurs in about 1 in 10,000 people a year.
Methods and outcomes
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent progression from retinal breaks or lattice degeneration to retinal detachment? What are the effects of different surgical interventions in people with rhegmatogenous retinal detachment? What are the effects of interventions to treat proliferative vitreoretinopathy occurring as a complication of retinal detachment or previous treatment for retinal detachment? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results
We found 21 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions
In this systematic review, we present information relating to the effectiveness and safety of the following interventions: corticosteroids, cryotherapy, daunorubicin, fluorouracil plus low molecular weight heparin, laser photocoagulation, pneumatic retinopexy, scleral buckling, short-acting or long-acting gas tamponade, silicone oil tamponade, and vitrectomy.
Key Points
Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment, where a retinal "break" allows the ingress of fluid from the vitreous cavity to the subretinal space, resulting in retinal separation. It occurs in about 1 in 10,000 people a year.
This review considers only acute progressive RRD.
Cryotherapy and photocoagulation are widely used for preventing progression from retinal breaks or lattice degeneration to RRD, and there is consensus that they are effective, particularly in people with symptomatic flap tears and retinal dialysis.
There is consensus that scleral buckling, pneumatic retinopexy, and vitrectomy are all effective for treating RRD.
We found insufficient evidence to assess effects of scleral buckling compared with pneumatic retinopexy.
The effects of scleral buckling compared with primary vitrectomy are unclear. There is limited evidence that, in phakic RRD, scleral buckling improves visual acuity at 1 year, and is associated with a reduced risk of development or progression of cataract. However, in pseudophakic and aphakic RRD, rates of retinal re-attachment after one operation are lower post scleral buckling compared with post-vitrectomy.
In people undergoing vitrectomy for RRD with severe proliferative vitreoretinopathy (occurring as a complication of retinal detachment or previous treatment for retinal detachment), silicone oil and long-acting gas are equally effective for increasing re-attachment rates and improving visual acuity; silicone oil is better than short-acting gas.
We found insufficient evidence assessing the effects of fluorouracil plus heparin, corticosteroids, or daunorubicin given during vitrectomy surgery for proliferative vitreoretinopathy.